39 results
Page 2 of 2
8-K
EX-99.1
cyp9cmgrx
29 Mar 22
Regulation FD Disclosure
7:43am
8-K
EX-99.1
6zvh3plz2 01928j85yd
7 Mar 22
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial and Business Highlights
4:11pm
10-K
4lzjz3qaqxo5mu4
7 Mar 22
Annual report
4:03pm
8-K
EX-99.2
d5kivx cnjxf
8 Nov 21
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
4:06pm
8-K
EX-99.1
nzc6hdj3vx0xew1f
8 Nov 21
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
4:06pm
8-K/A
EX-99.1
9hs152a
14 Sep 21
Eliem Therapeutics Reports Second Quarter Financial Results
8:01am
8-K
EX-99.1
dqhrudiish
13 Sep 21
Eliem Therapeutics Reports Second Quarter Financial Results
4:04pm
10-Q
raeihp1h3s
13 Sep 21
Quarterly report
4:01pm
424B4
dl1ae son90dr6aa6o
11 Aug 21
Prospectus supplement with pricing info
5:05pm
S-1/A
jcjx56f7fhg rw3tuwc
2 Aug 21
IPO registration (amended)
6:08am
S-1
grjwzw
16 Jul 21
IPO registration
5:02pm
DRS/A
0xoxp3wwf2cs 398ocp
12 Jul 21
Draft registration statement (amended)
12:00am
DRS/A
10x gqk5pri
21 Jun 21
Draft registration statement (amended)
12:00am
DRSLTR
w56tji0mhplq4qocbguh
21 Jun 21
Correspondence regarding draft registration statement
12:00am
UPLOAD
p8pvb2dh v6y0cpvpy
9 Jun 21
Letter from SEC
12:00am
DRS
76tlb9cjcdk zqri137
12 May 21
Draft registration statement
12:00am